Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India flag India · Delayed Price · Currency is INR
61.81
+2.94 (4.99%)
May 25, 2026, 9:49 AM IST

NSE:KREBSBIO Statistics

Total Valuation

NSE:KREBSBIO has a market cap or net worth of INR 1.22 billion. The enterprise value is 3.47 billion.

Market Cap1.22B
Enterprise Value 3.47B

Important Dates

The last earnings date was Thursday, May 21, 2026.

Earnings Date May 21, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 21.56M
Shares Outstanding n/a
Shares Change (YoY) +0.05%
Shares Change (QoQ) -0.45%
Owned by Insiders (%) 26.68%
Owned by Institutions (%) 0.00%
Float 4.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.73
PB Ratio -0.75
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -20.46
EV / Sales 13.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -68.05

Financial Position

The company has a current ratio of 0.09

Current Ratio 0.09
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -44.16
Interest Coverage -1.39

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -3.70%
Return on Invested Capital (ROIC) -9.61%
Return on Capital Employed (ROCE) -19.62%
Weighted Average Cost of Capital (WACC) 4.63%
Revenue Per Employee 1.28M
Profits Per Employee -838,272
Employee Count202
Asset Turnover 0.16
Inventory Turnover 0.06

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.87% in the last 52 weeks. The beta is 0.79, so NSE:KREBSBIO's price volatility has been lower than the market average.

Beta (5Y) 0.79
52-Week Price Change -20.87%
50-Day Moving Average 55.74
200-Day Moving Average 65.04
Relative Strength Index (RSI) 52.82
Average Volume (20 Days) 3,055

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:KREBSBIO had revenue of INR 257.58 million and -169.33 million in losses. Loss per share was -7.85.

Revenue257.58M
Gross Profit 253.67M
Operating Income -98.47M
Pretax Income -169.33M
Net Income -169.33M
EBITDA -34.24M
EBIT -98.47M
Loss Per Share -7.85
Full Income Statement

Balance Sheet

The company has 1.29 million in cash and 2.25 billion in debt, with a net cash position of -2.25 billion.

Cash & Cash Equivalents 1.29M
Total Debt 2.25B
Net Cash -2.25B
Net Cash Per Share n/a
Equity (Book Value) -1.63B
Book Value Per Share -75.83
Working Capital -1.03B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.21 million and capital expenditures -31.72 million, giving a free cash flow of -50.92 million.

Operating Cash Flow -19.21M
Capital Expenditures -31.72M
Depreciation & Amortization 64.23M
Net Borrowing 126.30M
Free Cash Flow -50.92M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 98.48%, with operating and profit margins of -38.23% and -65.74%.

Gross Margin 98.48%
Operating Margin -38.23%
Pretax Margin -65.74%
Profit Margin -65.74%
EBITDA Margin -13.29%
EBIT Margin -38.23%
FCF Margin n/a

Dividends & Yields

NSE:KREBSBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.05%
Shareholder Yield -0.05%
Earnings Yield -13.90%
FCF Yield -4.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2